{"id":22062,"date":"2021-11-29T14:17:18","date_gmt":"2021-11-29T13:17:18","guid":{"rendered":"https:\/\/www.fundacionisabelgemio.com\/wp-content\/uploads\/2021\/11\/TA-9-2021-0470_ES.pdf"},"modified":"2021-11-29T14:17:18","modified_gmt":"2021-11-29T13:17:18","slug":"ta-9-2021-0470_es-2","status":"inherit","type":"attachment","link":"https:\/\/www.fundacionisabelgemio.com\/fr\/non-classifiee\/aprobada-la-resolucion-del-parlamento-europeo-sobre-una-estrategia-farmaceutica-para-europa\/attachment\/ta-9-2021-0470_es-2","title":{"rendered":"Resolucion PE Estrategia Farmac\u00e9utica para Europa"},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0},"class_list":["post-22062","attachment","type-attachment","status-inherit","hentry"],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.fundacionisabelgemio.com\/wp-content\/uploads\/2021\/11\/TA-9-2021-0470_ES.pdf'>Resolucion PE Estrategia Farmac\u00e9utica para Europa<\/a><\/p>\n"},"caption":{"rendered":"<p>Resolucion PE Estrategia Farmac\u00e9utica para Europa<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":14347,"source_url":"https:\/\/www.fundacionisabelgemio.com\/wp-content\/uploads\/2021\/11\/TA-9-2021-0470_ES.pdf","_links":{"self":[{"href":"https:\/\/www.fundacionisabelgemio.com\/fr\/wp-json\/wp\/v2\/media\/22062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fundacionisabelgemio.com\/fr\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.fundacionisabelgemio.com\/fr\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/fr\/wp-json\/wp\/v2\/comments?post=22062"}]}}